Patents
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
06/2009
06/11/2009US20090149438 Pyrimidines as PLK inhibitors
06/11/2009US20090149425 Malononitrile compound as pesticides
06/11/2009US20090148531 Rate-controlled particles
06/11/2009CA2707989A1 Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
06/11/2009CA2707822A1 New compounds iii
06/11/2009CA2707722A1 Gamma secretase modulators
06/11/2009CA2707712A1 Gamma secretase modulators
06/11/2009CA2707653A1 Diaminopyridines for the treatment of diseases which are characterised by excessive or anomal cell proliferation
06/11/2009CA2707651A1 1,2-disubstituted-4-benzylamino-pyrrolidine derivatives as cetp inhibitors useful for the treatment of diseases such as hyperli pidemia or arteriosclerosis
06/10/2009EP2066666A1 Pyrazolopyridine, indazole, imidazopyridine, imidazopyrimidine, pyrazolopyrazine and pyrazolopyridine derivates as stimulators of guanylate cyclase for cardiovascular disorders
06/10/2009EP2066659A1 Substituted sulfonamide derivatives
06/10/2009EP2066654A1 N-(1-hetarylpiperidin-4-yl)(het)arylamides as ep2 receptor modulators
06/10/2009EP2066653A1 6-1h-imidazo-quinazoline and quinolines derivatives, new potent analgesics and anti-inflammatory agents
06/10/2009EP2066649A1 Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
06/10/2009EP2066643A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides and against arthropods
06/10/2009EP2066627A1 Novel minor groove binders
06/10/2009EP2066326A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors
06/10/2009EP2066319A1 Benzotriazole kinase modulators
06/10/2009EP2066318A2 Oxindole derivatives as anticancer agents
06/10/2009EP1597251B1 Pyrimidine compounds
06/10/2009EP1414797B9 Hepatitis c virus polymerase inhibitors with a heterobicylic structure
06/10/2009EP0976737B1 Pyrazole derivatives, process for preparing the same, intermediates, and pest control agent containing the same as active ingredient
06/10/2009CN101454314A Kinase inhibitors
06/10/2009CN101454313A P38 inhibitors and methods of use thereof
06/10/2009CN101454312A 2-carbocycloamino-4-imidaz0lylpyrimidines as agents for the inhbition of cell proliferation
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/10/2009CN100497333C Dihydrobenzodiazepin-2-one derivatives for the treatment of neurological disorders
06/10/2009CN100496490C Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-II receptor blockers for the treatment of cardiovascular diseases
06/09/2009US7544812 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus
06/09/2009US7544708 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide
06/09/2009US7544702 Bisaryl-sulfonamides
06/09/2009US7544690 MCH receptor antagonists
06/09/2009US7544688 Hetereoaryl nitrile derivatives
06/09/2009US7544684 Hydrazono-malonitriles
06/09/2009US7544675 Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions
06/09/2009US7544312 Charge transport compositions and electronic devices made with such compositions
06/09/2009CA2583764C Thrombopoietin activity modulating compounds and methods
06/04/2009WO2009070241A2 Angiotensin ii receptor antagonists
06/04/2009WO2009070172A1 Curable resins containing acetal, ketal, acetal ester, or ketal ester linkages
06/04/2009WO2009068652A1 2, 6-disubstituted pyridines and 2, 4-disubstituted pyrimidines as soluble guanylate cyclase activators
06/04/2009WO2009068512A1 2 -amino-pyrimidine derivatives as histamine h4 antagonists
06/04/2009WO2009016514A3 1, 3 and 1, 3, 5 substituted imidazoles as antihypertensiva
06/04/2009WO2009004427A3 Benzimidazole derivatives
06/04/2009WO2001060458A3 Inhibitors of prenyl-protein transferase
06/04/2009US20090143591 Scalable synthesis of imidazole derivatives
06/04/2009US20090143583 Transfection reagents
06/04/2009US20090143579 Heterocyclic Inhibitors of MEK and Methods of Use Thereof
06/04/2009US20090143575 Vanilloid receptor ligands and their use in treatments
06/04/2009US20090143454 Pyrazoline Derivatives and Their Use As Pesticides
06/04/2009US20090143440 Pyrazoles Useful in the Treatment of Inflammation
06/04/2009US20090143422 P38 inhibitors and methods of use thereof
06/04/2009US20090143414 Quinazoline Derivatives Having Tyrosine Kinase Inhibitory Activity
06/04/2009US20090143406 New Phenylpiperazine
06/04/2009US20090143405 1-{[1-(2,6-dimethylphenyl)-1H-tetrazol-5-yl]phenylmethyl}-4-(3-phenylallyl)piperazine; G-protein coupled receptor antagonist; antidepressant, anxiolitic agent, obesity
06/04/2009US20090143401 Pyridine and Pyrimidine Derivatives as Inhibitors of Histone Deacetylase
06/04/2009US20090143398 trans-N-(4-{2-[4-(5,6-dichloro-2-methylamino-pyrimidin-4-yl)-piperazin-1-yl]-ethyl]-cyclohexyl}-acetamide; for treating Parkinson's disease; reacting trans-(4-{4-[2-(4-amino-cyclohexyl)-ethyl]-piperazin-1-yl}-5,6-dichloro-pyrimidin-2-yl)-methyl-amine trihydrochloride with acetyl chloride
06/04/2009US20090143394 Compounds for activating tgf-beta signaling
06/04/2009US20090143389 Heterocyclic inhibitors of mek and methods of use thereof
06/04/2009US20090143384 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer
06/04/2009US20090143383 Aryloxyethylamine compounds suitable for treating disorders that respond to modulation of the dopamine d3 receptor
06/04/2009US20090143370 Non-nucleoside Reverse Transcriptase Inhibitors
06/04/2009US20090143364 Chiral cis-imidazolines
06/04/2009US20090143345 Thioamide derivatives as progesterone receptor modulators
06/04/2009US20090142832 Indoles, Derivatives, and Analogs Thereof and Uses Therefor
06/04/2009US20090142554 Yellow Azo Dyes for Ink Jet Printing
06/04/2009US20090142347 Tissue-Nonspecific Alkaline Phosphatase (TNAP): a Therapeutic Target for Arterial Calcification
06/04/2009US20090142297 5-substituted isoindoline compounds
06/04/2009US20090142279 Novel m3 muscarinic acetylcholine receptor antagonists
06/04/2009DE112007001117T5 Gaserzeugungsmittelzusammensetzungen Gas generant compositions
06/04/2009CA2705262A1 Angiotensin ii receptor antagonists
06/03/2009EP2065383A1 Indazole compounds and methods of use thereof as protein kinase inhibitors
06/03/2009EP2065368A1 Inhibitors of IAP
06/03/2009EP2064190A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods
06/03/2009EP2064184A1 Multimeric heterocyclic compounds useful as neutrophil elastase inhibitors
06/03/2009EP2064181A1 4, 5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
06/03/2009EP2064180A1 4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
06/03/2009EP2063894A2 Formulations containing pyridazine compounds for treating neuroinflammatory diseases
06/03/2009EP1765788B1 3-aminoindazole derivatives and their use for the treatment of sgk-associated diseases
06/03/2009EP1667679B1 Aminobenzimidazoles as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
06/03/2009EP1263720B1 Azetidine derivatives, preparation thereof and pharmaceutical compositions containing same
06/03/2009EP1071668B1 5-aminoindeno[1,2-c]pyrazol-4-ones as anti-cancer and anti-proliferative agents
06/03/2009CN101448823A Maleate co-crystal of AZD1152
06/03/2009CN101445502A Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
06/03/2009CN101445501A Fused compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor
06/03/2009CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
06/03/2009CN100494192C Double heterocyclic compound containing pyrazole and benzimidazole, preparing method and its use
06/03/2009CN100494182C Regulatory factor of tumor necrosis alpha factor
06/02/2009US7541477 hormone inhibitor 5-(4-fluorophenyl)-N-{2-[isopropyl(methyl)amino]-1H-benzimidazol-6-yl}-2-pyridinecarboxamide; treating the disorders of cardiovascular system, nervous system, metabolic systems, reproductive system, respiratory system, digestive system
06/02/2009US7541370 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
06/02/2009US7541361 N-[4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use
06/02/2009US7541357 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
06/02/2009US7541354 Bicyclo-pyrazoles
06/02/2009US7541096 Blue emitting, durable, organoelectrouminescent layers containing 2H-benzotriazole compounds; full color display panels; light emission efficiency and brightness
06/02/2009CA2516433C Ramosetron hydrochloride for diarrhea-predominant irritable bowel syndrome
06/02/2009CA2410160C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and alkylating agents
06/02/2009CA2377230C Benzimidazole compounds and medicaments comprising the same
06/02/2009CA2344290C Quinazoline derivatives
06/02/2009CA2304425C Novel pyrazolone compound and ophthalmic plastic lens using the same
06/02/2009CA2287551C 3-(2-pyrrolidinylmethyl)-indole compounds having 5-ht6 affinity